Stockholm - Delayed Quote SEK

CHOSA Oncology AB (CHOSA.ST)

0.7750
-0.0300
(-3.73%)
At close: 5:29:54 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
9,714
9,714
23,512
1,167
61,856.7040
Operating Income
-9,714
-9,714
-23,512
-1,167
-61,856.7040
Net Non Operating Interest Income Expense
121
121
-240
0
-204.0620
Pretax Income
-9,594
-9,594
-23,752
-1,167
-62,076.5550
Tax Provision
0
0
191
-146
-7,502.5280
Net Income Common Stockholders
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Diluted NI Available to Com Stockholders
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Basic EPS
-0.14
--
-0.37
-0.05
-2.87
Diluted EPS
-0.14
--
-0.37
-0.05
-2.87
Basic Average Shares
70,944.1460
--
64,873.9130
19,047.1020
19,047.1020
Diluted Average Shares
70,944.1460
--
64,873.9130
19,047.1020
19,047.1020
Total Operating Income as Reported
-9,714
-9,714
-23,512
-1,167
-61,856.7040
Total Expenses
9,714
9,714
23,512
1,167
61,856.7040
Net Income from Continuing & Discontinued Operation
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Normalized Income
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Interest Income
394
394
303
0
0
Interest Expense
273
273
543
0
204.0620
Net Interest Income
121
121
-240
0
-204.0620
EBIT
-9,321
-9,321
-23,209
-1,167
-61,872.4930
EBITDA
-8,637
-8,637
-22,439
-667
-61,872.4930
Reconciled Depreciation
684
684
770
500
--
Net Income from Continuing Operation Net Minority Interest
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Normalized EBITDA
-8,637
-8,637
-22,439
-667
-61,872.4930
Tax Rate for Calcs
0
0
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/9/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LIDDS.ST LIDDS AB (publ)
0.0478
-7.00%
 
QUIA.ST Quia Pharma AB (publ)
0.0052
-7.14%
 
SPRINT.ST Sprint Bioscience AB (publ)
0.4170
-0.24%
 
SIMRIS-B.ST Simris Group AB (PUBL)
0.1325
+1.92%
 
DBP-B.ST Double Bond Pharmaceutical Int.
0.1330
+8.13%
 
HMGN Hemagen Diagnostics, Inc.
0.0001
0.00%
 
PCIB.OL PCI Biotech Holding ASA
1.5850
-4.23%
 
IMMU.ST Mendus AB (publ)
5.18
-2.45%
 
GENO.ST Genovis AB (publ.)
25.45
-0.39%
 
ERGO Entia Biosciences, Inc.
0.0002
+100.00%